
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation
Huy Hoang Dang, Hoang Dang Khoa Ta, Truc T.T. Nguyen, et al.
Functional & Integrative Genomics (2022) Vol. 22, Iss. 5, pp. 1057-1072
Closed Access | Times Cited: 48
Huy Hoang Dang, Hoang Dang Khoa Ta, Truc T.T. Nguyen, et al.
Functional & Integrative Genomics (2022) Vol. 22, Iss. 5, pp. 1057-1072
Closed Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis
Thi-Oanh Tran, Thanh Hoa Vo, Luu Ho Thanh Lam, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1921-1929
Open Access | Times Cited: 49
Thi-Oanh Tran, Thanh Hoa Vo, Luu Ho Thanh Lam, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1921-1929
Open Access | Times Cited: 49
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
Lirui Dai, Xuyang Guo, Zhe Xing, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Lirui Dai, Xuyang Guo, Zhe Xing, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression
Li Tong, Xiaofei Zheng, Tianqi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 5
Li Tong, Xiaofei Zheng, Tianqi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 5
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer
Thi-Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Thi-Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
Hua Huang, Huibo Lian, Wang Liu, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
Hua Huang, Huibo Lian, Wang Liu, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
Development and Validation of Novel Deep-Learning Models Using Multiple Data Types for Lung Cancer Survival
Jason C. Hsu, Phung‐Anh Nguyen, Phan Thanh Phuc, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5562-5562
Open Access | Times Cited: 13
Jason C. Hsu, Phung‐Anh Nguyen, Phan Thanh Phuc, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5562-5562
Open Access | Times Cited: 13
Identification of a Novel Eight-Gene Risk Model for Predicting Survival in Glioblastoma: A Comprehensive Bioinformatic Analysis
Huy-Hoang Dang, Hoang Dang Khoa Ta, Truc T.T. Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3899-3899
Open Access | Times Cited: 7
Huy-Hoang Dang, Hoang Dang Khoa Ta, Truc T.T. Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3899-3899
Open Access | Times Cited: 7
Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy
Hao Lai, Xiaoyun Xiang, Xingqing Long, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 107-121
Closed Access | Times Cited: 2
Hao Lai, Xiaoyun Xiang, Xingqing Long, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 107-121
Closed Access | Times Cited: 2
The association of genomic alterations with PD‐L1 expression in Chinese patients with EGFR /ALK wild‐type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy
Fangfang Liu, X. Zhang, Mengyao Lu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Fangfang Liu, X. Zhang, Mengyao Lu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Depletion of CPNE7 sensitizes colorectal cancer to 5‐fluorouracil by downregulating ATG9B expression
W Xu, Yujie Tang, Yang Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
W Xu, Yujie Tang, Yang Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target
Yanjun Li, Wenke Yang, Chaojun Liu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111918-111918
Closed Access | Times Cited: 2
Yanjun Li, Wenke Yang, Chaojun Liu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111918-111918
Closed Access | Times Cited: 2
A comprehensive prognostic and immune infiltration analysis of UBA1 in pan‐cancer: A computational analysis and in vitro experiments
Can Chen, Yiwei Li, Zhenzhen Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
Can Chen, Yiwei Li, Zhenzhen Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
Qin Yang, Xi Yong, Xiaoli Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 19
Open Access | Times Cited: 2
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
Lirui Dai, Yongjie Han, Zhuo Yang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 15, pp. 2194-2214
Open Access | Times Cited: 6
Lirui Dai, Yongjie Han, Zhuo Yang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 15, pp. 2194-2214
Open Access | Times Cited: 6
Comprehensive analysis of the role of SFXN family in breast cancer
Yuan Ding, Jialiang Liu, Wenbo Sang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Yuan Ding, Jialiang Liu, Wenbo Sang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
Niu Niu, Liang Zhou, Junjie Zhao, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Niu Niu, Liang Zhou, Junjie Zhao, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model
Rayan Nassani, Yahya Bokhari, Bahauddeen M. Alrfaei
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0287448-e0287448
Open Access | Times Cited: 5
Rayan Nassani, Yahya Bokhari, Bahauddeen M. Alrfaei
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0287448-e0287448
Open Access | Times Cited: 5
A novel disulfidptosis-related gene signature predicts overall survival of glioblastoma patients
Yuxia Zhang, Bing Liu, Y.-H. Zhou
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Yuxia Zhang, Bing Liu, Y.-H. Zhou
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Abnormal expression of Krüppel-like transcription factors and their potential values in lung cancer
Yang Shi, Min Yao, Shuijie Shen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28292-e28292
Open Access | Times Cited: 1
Yang Shi, Min Yao, Shuijie Shen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28292-e28292
Open Access | Times Cited: 1
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Ling Lv, Xin Zhang, Yajun Liu, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 171-181
Open Access | Times Cited: 1
Ling Lv, Xin Zhang, Yajun Liu, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 171-181
Open Access | Times Cited: 1
IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma
Jiannan Hu, Chuan-Jing Dai, Zhaoji Ding, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Jiannan Hu, Chuan-Jing Dai, Zhaoji Ding, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Ferroptosis patterns modulate immunocyte communication in tumor microenvironments: clinical value and therapeutic guidance of lung adenocarcinoma
Peng Wang, Ye Wang, Yu Wang
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Closed Access | Times Cited: 3
Peng Wang, Ye Wang, Yu Wang
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Closed Access | Times Cited: 3
Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by Bioinformatics and Experiments
Zhipeng Du, Zhongchao Zhang, Xu Han, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 10, pp. 1300-1315
Open Access | Times Cited: 3
Zhipeng Du, Zhongchao Zhang, Xu Han, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 10, pp. 1300-1315
Open Access | Times Cited: 3
β‐elemene enhances cisplatin sensitivity of non‐small cell lung cancer cells via the miR‐17‐5p/STAT3 axis
Qian Tian, Tong Wenxian, Anbing He
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 3
Qian Tian, Tong Wenxian, Anbing He
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 3